Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Verapamil in Chronic Rhinosinusitis with Nasal Polyps
NCT03102190Phase 1Terminated
- Start
- Jun 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of verapamil in chronic rhinosinusitis with nasal polyps (CRSwNP). Primary endpoint: Dose Limiting Toxicity. Started Jun 2017; status: terminated.
02
Drugs
verapamil
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT03102190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102190.